Arcturus Therapeutics Holdings Inc (NQ: ARCT )
32.80
USD
-2.29
(-6.53%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 21, 2021
Add to My Watchlist
All news about Arcturus Therapeutics Holdings Inc
From Benzinga
From Benzinga
10 Biggest Price Target Changes For Monday
June 21, 2021
From Benzinga
From Benzinga
7 Best Vaccine Stocks for Their Pipeline Potential
June 03, 2021
From InvestorPlace
Primordial Genetics Grants Arcturus Therapeutics Exclusive License of an RNA Polymerase for Human and Animal Therapeutics
June 02, 2021
From PR Newswire
High Flyers At Much Lower Altitudes
May 14, 2021
Stocks with extreme valuations have taken a serious haircut since the space peaked on February 22nd.
From Blogs - TalkMarkets
From Benzinga
From Benzinga
From Benzinga
Arcturus Therapeutics: Q1 Earnings Insights
May 10, 2021
From Benzinga
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
May 09, 2021
From Benzinga
From Benzinga
Tags
Stocks
From Market News Video
Could These 3 Brilliant mRNA Stocks Make You Millions?
April 30, 2021
From Motley Fool
From Motley Fool
Stock Upgrades: Alcobra Shows Rising Relative Strength
March 12, 2021
Tags
Stocks
From Market News Video
Arcturus Therapeutics: Q4 Earnings Insights
March 01, 2021
From Benzinga
Earnings Scheduled For March 1, 2021
March 01, 2021
From Benzinga
The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings
February 27, 2021
From Benzinga
Arcturus Therapeutics Holdings Breaks Below 200-Day Moving Average - Notable for ARCT
February 23, 2021
Tags
Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Market Action
MARKET NEWS
Home | Individual investors | Institutional investors | Find an advisor | Opportunities at Winslow | About | News | Contact | Mobile | Site map
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker
Investing involves risk including loss of principal. Securities and Variable Insurance Products offered through National Securities Corporation, member FINRA/ SIPC. Fee-based investment advisory services offered through National Asset Management, an SEC registered investment advisor. Insurance products, including fixed indexed annuities offered through National Insurance Corporation.
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker
Investing involves risk including loss of principal. Securities and Variable Insurance Products offered through National Securities Corporation, member FINRA/ SIPC. Fee-based investment advisory services offered through National Asset Management, an SEC registered investment advisor. Insurance products, including fixed indexed annuities offered through National Insurance Corporation.